These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7537539

  • 1. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice.
    Connelly S, Smith TA, Dhir G, Gardner JM, Mehaffey MG, Zaret KS, McClelland A, Kaleko M.
    Hum Gene Ther; 1995 Feb; 6(2):185-93. PubMed ID: 7537539
    [Abstract] [Full Text] [Related]

  • 2. High-level tissue-specific expression of functional human factor VIII in mice.
    Connelly S, Gardner JM, McClelland A, Kaleko M.
    Hum Gene Ther; 1996 Jan 20; 7(2):183-95. PubMed ID: 8788169
    [Abstract] [Full Text] [Related]

  • 3. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice.
    Gallo-Penn AM, Shirley PS, Andrews JL, Kayda DB, Pinkstaff AM, Kaloss M, Tinlin S, Cameron C, Notley C, Hough C, Lillicrap D, Kaleko M, Connelly S.
    Hum Gene Ther; 1999 Jul 20; 10(11):1791-802. PubMed ID: 10446919
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced plasma factor VIII activity in mice via cysteine mutation using dual vectors.
    Zhu F, Liu Z, Miao J, Qu H, Chi X.
    Sci China Life Sci; 2012 Jun 20; 55(6):521-6. PubMed ID: 22744182
    [Abstract] [Full Text] [Related]

  • 7. Sustaining expression of B domain-deleted human factor VIII mediated by using lentiviral vectors in NOD/SCID mouse.
    Li YJ, Chen C, Zeng LY, Cao J, Xu KL.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun 20; 20(3):658-63. PubMed ID: 22739177
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vivo evaluation of a novel epitope-tagged human factor VIII-encoding adenoviral vector.
    Roy S, Shirley PS, Connelly S, Andrews JL, Kayda DB, Gardner JM, Kaleko M.
    Haemophilia; 1999 Sep 20; 5(5):340-8. PubMed ID: 10583516
    [Abstract] [Full Text] [Related]

  • 10. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
    Bristol JA, Gallo-Penn A, Andrews J, Idamakanti N, Kaleko M, Connelly S.
    Hum Gene Ther; 2001 Sep 01; 12(13):1651-61. PubMed ID: 11535168
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.
    Chuah MK, VandenDriessche T, Morgan RA.
    Hum Gene Ther; 1995 Nov 01; 6(11):1363-77. PubMed ID: 8573610
    [Abstract] [Full Text] [Related]

  • 14. Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector.
    Reddy PS, Sakhuja K, Ganesh S, Yang L, Kayda D, Brann T, Pattison S, Golightly D, Idamakanti N, Pinkstaff A, Kaloss M, Barjot C, Chamberlain JS, Kaleko M, Connelly S.
    Mol Ther; 2002 Jan 01; 5(1):63-73. PubMed ID: 11786047
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of factor VIII transgenes bioengineered for improved expression in gene therapy of hemophilia A.
    Dooriss KL, Denning G, Gangadharan B, Javazon EH, McCarty DA, Spencer HT, Doering CB.
    Hum Gene Ther; 2009 May 01; 20(5):465-78. PubMed ID: 19222367
    [Abstract] [Full Text] [Related]

  • 18. Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A.
    Zhang WW, Josephs SF, Zhou J, Fang X, Alemany R, Balagué C, Dai Y, Ayares D, Prokopenko E, Lou YC, Sethi E, Hubert-Leslie D, Kennedy M, Ruiz L, Rockow-Magnone S.
    Thromb Haemost; 1999 Aug 01; 82(2):562-71. PubMed ID: 10605752
    [Abstract] [Full Text] [Related]

  • 19. In vivo dose threshold effect of adenovirus-mediated factor VIII gene therapy in hemophiliac mice.
    Bristol JA, Shirley P, Idamakanti N, Kaleko M, Connelly S.
    Mol Ther; 2000 Sep 01; 2(3):223-32. PubMed ID: 10985953
    [Abstract] [Full Text] [Related]

  • 20. Sustained expression of therapeutic levels of human factor VIII in mice.
    Connelly S, Gardner JM, Lyons RM, McClelland A, Kaleko M.
    Blood; 1996 Jun 01; 87(11):4671-7. PubMed ID: 8639836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.